FARALLON CAPITAL MANAGEMENT LLC
Q1 2020 13F-HR Holdings
Net value change ($000)
-1,037,237
(-8.3%)
New positions
15
Sold out positions
30
Turnover %
36.7%
Sector allocation + QoQ delta (equities-only)
Holdings aggregated across other managers listed in the original SEC filing. View detailed breakdown
Snapshot: Change Analysis
Compared to Q4 2019
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| Allergan plc | 1,647,030 | NEW |
| CNC | 430,723 | NEW |
| IQV | 116,796 | 40.8% |
| Forty Seven, Inc. | 105,439 | NEW |
| GD | 102,628 | 59.3% |
| XLRN | 89,427 | 84.3% |
| IHS Markit Ltd. | 88,806 | 43.0% |
| ABBV | 83,410 | 37.7% |
| FIS | 77,290 | 15.9% |
| TMO | 75,410 | 27.2% |
Top Reduces (Value $000, Stocks/ETFs)
| MEDICINES CO /DE | -281,576 | -100.0% |
| Zayo Group Holdings, Inc. | -236,313 | -100.0% |
| MTCH | -207,407 | -40.3% |
| Playa Hotels & Resorts N.V. | -203,536 | -79.2% |
| SPGI | -174,856 | -100.0% |
| MyoKardia, Inc. | -129,256 | -86.5% |
| PANW | -94,538 | -36.9% |
| ELV | -93,738 | -24.8% |
| WAB | -90,088 | -22.8% |
| CI | -85,260 | -27.8% |
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000):
739,484
(6.5% of total reported value)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|